Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma - PubMed (original) (raw)
. 2005 Apr 20;114(4):563-71.
doi: 10.1002/ijc.20773.
Affiliations
- PMID: 15609334
- DOI: 10.1002/ijc.20773
Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma
Stacy Moore et al. Int J Cancer. 2005.
Abstract
Prostate carcinogenesis is influenced by genetic alterations resulting in a biochemical condition that favors cell proliferation and survival. Studies of prostate carcinoma using comparative genomic hybridization and cDNA microarray analysis indicate that numerous biochemical processes may be affected during cellular transformation and progression to an invasive phenotype. Among the consistently observed tumor-associated changes are alterations in fatty acid metabolism that influence diverse cellular activities such as signaling, energy utilization, and membrane fluidity. Increases in fatty acid synthase (FAS) levels have been shown to be one of the earliest and most frequent molecular alterations in prostate carcinogenesis. We sought to identify tumor-associated changes in the expression of genes with functional roles associated with lipid metabolism. Defined populations of normal and neoplastic prostate epithelium were acquired by laser capture microdissection and transcript levels were measured by cDNA microarray hybridization. We determined that stearoyl-CoA desaturase (SCD) transcripts were downregulated in cancer relative to normal epithelium. These results were confirmed by quantitative PCR. Further analysis by immunohistochemical evaluation of radical prostatectomy samples employed a quantitative scoring system with a range of 0-300. The median SCD expression levels were 150, 45 and 10 for normal, PIN and carcinoma samples, respectively. Statistically significant differential SCD expression between normal and cancerous epithelium was determined at the p=0.001 level, and between PIN and prostate carcinoma at the p=0.03 level. Of these cases, 92% overexpressed fatty acid synthase (FAS) in cancerous cells and 84.7% exhibited the signature of FAS overexpression and SCD loss in prostate carcinoma as compared to normal prostate epithelium. These results indicate that loss of SCD expression is a frequent event in prostate adenocarcinoma, and further supports a role for altered lipid metabolism as a factor in the process of carcinogenesis.
Similar articles
- Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
Huang CY, Beer TM, Higano CS, True LD, Vessella R, Lange PH, Garzotto M, Nelson PS. Huang CY, et al. Clin Cancer Res. 2007 Oct 1;13(19):5825-33. doi: 10.1158/1078-0432.CCR-07-1037. Clin Cancer Res. 2007. PMID: 17908975 Clinical Trial. - Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. Rossi S, et al. Mol Cancer Res. 2003 Aug;1(10):707-15. Mol Cancer Res. 2003. PMID: 12939396 - Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R, Jerónimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, Oliveira J, Lopes C, Sidransky D. Henrique R, et al. Mol Cancer Res. 2006 Jan;4(1):1-8. doi: 10.1158/1541-7786.MCR-05-0113. Mol Cancer Res. 2006. PMID: 16446401 - Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.
Igal RA. Igal RA. Carcinogenesis. 2010 Sep;31(9):1509-15. doi: 10.1093/carcin/bgq131. Epub 2010 Jul 1. Carcinogenesis. 2010. PMID: 20595235 Review. - Role of stearoyl-coenzyme A desaturase in lipid metabolism.
Miyazaki M, Ntambi JM. Miyazaki M, et al. Prostaglandins Leukot Essent Fatty Acids. 2003 Feb;68(2):113-21. doi: 10.1016/s0952-3278(02)00261-2. Prostaglandins Leukot Essent Fatty Acids. 2003. PMID: 12538075 Review.
Cited by
- Cell type-specific analyses for identifying prostate cancer biomarkers.
Nelson PS, Montgomery B. Nelson PS, et al. Curr Urol Rep. 2006 Jan;7(1):57-63. doi: 10.1007/s11934-006-0039-4. Curr Urol Rep. 2006. PMID: 16480670 Review. - PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.
Strand DW, Jiang M, Murphy TA, Yi Y, Konvinse KC, Franco OE, Wang Y, Young JD, Hayward SW. Strand DW, et al. Cell Death Dis. 2012 Aug 9;3(8):e361. doi: 10.1038/cddis.2012.99. Cell Death Dis. 2012. PMID: 22874998 Free PMC article. - NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells.
Kailavasan M, Rehman I, Reynolds S, Bucur A, Tozer G, Paley M. Kailavasan M, et al. NMR Biomed. 2014 May;27(5):610-6. doi: 10.1002/nbm.3101. Epub 2014 Mar 17. NMR Biomed. 2014. PMID: 24639007 Free PMC article. - Lipid metabolism in prostate cancer.
Wu X, Daniels G, Lee P, Monaco ME. Wu X, et al. Am J Clin Exp Urol. 2014 Jul 12;2(2):111-20. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25374912 Free PMC article. Review. - Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP. Saraon P, et al. Mol Cell Proteomics. 2013 Jun;12(6):1589-601. doi: 10.1074/mcp.M112.023887. Epub 2013 Feb 26. Mol Cell Proteomics. 2013. PMID: 23443136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous